Question 1

What is Antengene?

Accepted Answer

Antengene is a Entity.

Question 2

How often does Antengene appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 28 articles.

Question 3

When was Antengene first tracked by Ergen?

Accepted Answer

First tracked on Jun 03, 2026.

Question 4

When was Antengene last mentioned in news?

Accepted Answer

Last active on Aug 19, 2026.

Question 5

What is Antengene's current news sentiment?

Accepted Answer

Aggregate sentiment score: 65 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Antengene in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving Antengene?

Accepted Answer

Antengene presents ATG-207 preclinical data (Jun 03, 2026, 7 articles).

Question 8

How did the "Antengene presents ATG-207 preclinical data" event impact Antengene?

Accepted Answer

Antengene is presenting the first preclinical data for its drug candidate ATG-207, which could positively impact its stock price and future revenue streams if the drug progresses successfully through clinical trials.

Question 9

How did the "Antengene ATG-201 IND Approval China" event impact Antengene?

Accepted Answer

Antengene received IND approval for ATG-201 in China, marking a significant expansion into autoimmune diseases and potentially increasing its market value and strategic importance. Antengene will conduct initial clinical trials in China and Australia before transferring development to EITC.

Question 10

How did the "Antengene receives $60M from UCB" event impact Antengene?

Accepted Answer

Antengene received a USD 60 million upfront payment from UCB, strengthening its cash position and validating its ATG-201 program. The deal provides financial support for its pipeline and potential future milestones.

Question 11

How did the "Antengene presents R&D at Evercore Summit" event impact Antengene?

Accepted Answer

Antengene is the central entity, presenting its clinical data and pipeline advancements, which could enhance its valuation and competitive position.

Question 12

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.